Share Price and Basic Stock Data
Last Updated: April 24, 2025, 9:49 pm
| PEG Ratio | -3.48 |
|---|
Competitors of Dalmia Bharat Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 35.3/16.2 | 13.2 | 0.00 % | 11.8 % | 56.4 % | 10.0 | |
| UltraTech Cement Ltd | 3,58,324 Cr. | 12,159 | 12,188/9,408 | 57.2 | 2,126 | 0.58 % | 15.1 % | 12.2 % | 10.0 |
| The Ramco Cements Ltd | 23,357 Cr. | 988 | 1,060/700 | 122 | 302 | 0.25 % | 8.17 % | 5.63 % | 1.00 |
| The India Cements Ltd | 9,010 Cr. | 291 | 386/173 | 170 | 0.00 % | 0.78 % | 4.81 % | 10.0 | |
| Star Cement Ltd | 9,058 Cr. | 224 | 256/172 | 67.9 | 67.9 | 0.00 % | 16.5 % | 11.5 % | 1.00 |
| Industry Average | 37,262.26 Cr | 2,060.92 | 49.89 | 532.66 | 0.63% | 10.92% | 15.70% | 7.13 |
Quarterly Result
| Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,734 | 3,380 | 3,302 | 2,971 | 3,355 | 3,915 | 3,627 | 3,153 | 3,604 | 4,307 | 3,621 | 3,087 | 3,181 |
| Expenses | 2,323 | 2,697 | 2,713 | 2,592 | 2,711 | 3,205 | 3,014 | 2,560 | 2,825 | 3,653 | 2,952 | 2,653 | 2,670 |
| Operating Profit | 411 | 683 | 589 | 379 | 644 | 710 | 613 | 593 | 779 | 654 | 669 | 434 | 511 |
| OPM % | 15% | 20% | 18% | 13% | 19% | 18% | 17% | 19% | 22% | 15% | 18% | 14% | 16% |
| Other Income | 62 | 57 | 39 | 33 | 42 | 424 | 54 | 80 | 60 | 120 | -63 | 73 | 37 |
| Interest | 46 | 45 | 47 | 54 | 69 | 64 | 83 | 101 | 108 | 94 | 95 | 98 | 101 |
| Depreciation | 302 | 333 | 312 | 332 | 325 | 336 | 399 | 401 | 370 | 328 | 317 | 336 | 364 |
| Profit before tax | 125 | 362 | 269 | 26 | 292 | 734 | 185 | 171 | 361 | 352 | 194 | 73 | 83 |
| Tax % | 28% | 25% | 24% | -81% | 25% | 17% | 22% | 28% | 26% | 9% | 25% | 33% | 20% |
| Net Profit | 92 | 271 | 205 | 47 | 218 | 609 | 144 | 123 | 266 | 320 | 145 | 49 | 66 |
| EPS in Rs | 4.49 | 14.20 | 10.46 | 2.45 | 10.88 | 31.42 | 6.93 | 6.29 | 14.02 | 16.80 | 7.52 | 2.45 | 3.25 |
Last Updated: February 28, 2025, 8:14 pm
Below is a detailed analysis of the quarterly data for Dalmia Bharat Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is 3,181.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,087.00 Cr. (Sep 2024) to 3,181.00 Cr., marking an increase of 94.00 Cr..
- For Expenses, as of Dec 2024, the value is 2,670.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,653.00 Cr. (Sep 2024) to 2,670.00 Cr., marking an increase of 17.00 Cr..
- For Operating Profit, as of Dec 2024, the value is 511.00 Cr.. The value appears strong and on an upward trend. It has increased from 434.00 Cr. (Sep 2024) to 511.00 Cr., marking an increase of 77.00 Cr..
- For OPM %, as of Dec 2024, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 14.00% (Sep 2024) to 16.00%, marking an increase of 2.00%.
- For Other Income, as of Dec 2024, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 73.00 Cr. (Sep 2024) to 37.00 Cr., marking a decrease of 36.00 Cr..
- For Interest, as of Dec 2024, the value is 101.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 98.00 Cr. (Sep 2024) to 101.00 Cr., marking an increase of 3.00 Cr..
- For Depreciation, as of Dec 2024, the value is 364.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 336.00 Cr. (Sep 2024) to 364.00 Cr., marking an increase of 28.00 Cr..
- For Profit before tax, as of Dec 2024, the value is 83.00 Cr.. The value appears strong and on an upward trend. It has increased from 73.00 Cr. (Sep 2024) to 83.00 Cr., marking an increase of 10.00 Cr..
- For Tax %, as of Dec 2024, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 33.00% (Sep 2024) to 20.00%, marking a decrease of 13.00%.
- For Net Profit, as of Dec 2024, the value is 66.00 Cr.. The value appears strong and on an upward trend. It has increased from 49.00 Cr. (Sep 2024) to 66.00 Cr., marking an increase of 17.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is 3.25. The value appears strong and on an upward trend. It has increased from 2.45 (Sep 2024) to 3.25, marking an increase of 0.80.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 4:30 pm
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 7,444 | 8,579 | 9,484 | 9,674 | 10,110 | 11,286 | 13,552 | 14,691 | 14,196 |
| Expenses | 5,550 | 6,543 | 7,542 | 7,591 | 7,340 | 8,860 | 11,224 | 12,052 | 11,928 |
| Operating Profit | 1,894 | 2,036 | 1,942 | 2,083 | 2,770 | 2,426 | 2,328 | 2,639 | 2,268 |
| OPM % | 25% | 24% | 20% | 22% | 27% | 22% | 17% | 18% | 16% |
| Other Income | 296 | 274 | 235 | 217 | 145 | 171 | 532 | 314 | 167 |
| Interest | 856 | 708 | 542 | 415 | 303 | 202 | 234 | 386 | 388 |
| Depreciation | 1,226 | 1,213 | 1,296 | 1,528 | 1,250 | 1,235 | 1,305 | 1,498 | 1,345 |
| Profit before tax | 108 | 389 | 339 | 357 | 1,362 | 1,160 | 1,321 | 1,069 | 702 |
| Tax % | 69% | 25% | -3% | 33% | 13% | 27% | 18% | 20% | |
| Net Profit | 44 | 291 | 349 | 238 | 1,183 | 845 | 1,079 | 853 | 580 |
| EPS in Rs | 8,800.00 | 58,400.00 | 15.96 | 11.61 | 62.58 | 43.55 | 55.21 | 44.04 | 30.02 |
| Dividend Payout % | 0% | 1,937% | 13% | 17% | 2% | 20% | 16% | 21% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 561.36% | 19.93% | -31.81% | 397.06% | -28.57% | 27.69% | -20.95% |
| Change in YoY Net Profit Growth (%) | 0.00% | -541.43% | -51.74% | 428.86% | -425.63% | 56.26% | -48.64% |
Dalmia Bharat Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2017-2018 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 8% |
| 3 Years: | 7% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 33% |
| 3 Years: | 1% |
| TTM: | 1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 30% |
| 3 Years: | 7% |
| 1 Year: | 9% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 5% |
| Last Year: | 5% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 15, 2024, 12:39 am
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6,654 | 6,654 | 39 | 39 | 37 | 37 | 37 | 38 | 38 |
| Reserves | 2,975 | 3,681 | 10,600 | 10,522 | 12,773 | 16,024 | 15,591 | 16,359 | 17,480 |
| Borrowings | 8,038 | 7,266 | 5,883 | 6,049 | 3,839 | 3,176 | 3,855 | 4,805 | 4,931 |
| Other Liabilities | 3,595 | 3,763 | 4,016 | 4,268 | 5,237 | 5,431 | 6,036 | 6,510 | 6,589 |
| Total Liabilities | 21,262 | 21,364 | 20,538 | 20,878 | 21,886 | 24,668 | 25,519 | 27,712 | 29,038 |
| Fixed Assets | 15,516 | 14,037 | 13,573 | 12,555 | 13,626 | 14,147 | 14,784 | 15,732 | 16,077 |
| CWIP | 128 | 168 | 520 | 1,740 | 1,006 | 1,034 | 1,871 | 2,395 | 2,887 |
| Investments | 2,740 | 3,505 | 2,424 | 2,816 | 4,033 | 5,704 | 3,524 | 4,462 | 4,945 |
| Other Assets | 2,878 | 3,654 | 4,021 | 3,767 | 3,221 | 3,783 | 5,340 | 5,123 | 5,129 |
| Total Assets | 21,262 | 21,364 | 20,538 | 20,878 | 21,886 | 24,668 | 25,519 | 27,712 | 29,038 |
Below is a detailed analysis of the balance sheet data for Dalmia Bharat Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹38.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 38.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹17,480.00 Cr.. The value appears strong and on an upward trend. It has increased from 16,359.00 Cr. (Mar 2024) to ₹17,480.00 Cr., marking an increase of 1,121.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹4,931.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 4,805.00 Cr. (Mar 2024) to ₹4,931.00 Cr., marking an increase of 126.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹6,589.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,510.00 Cr. (Mar 2024) to ₹6,589.00 Cr., marking an increase of 79.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹29,038.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27,712.00 Cr. (Mar 2024) to ₹29,038.00 Cr., marking an increase of 1,326.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹16,077.00 Cr.. The value appears strong and on an upward trend. It has increased from 15,732.00 Cr. (Mar 2024) to ₹16,077.00 Cr., marking an increase of 345.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹2,887.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,395.00 Cr. (Mar 2024) to ₹2,887.00 Cr., marking an increase of 492.00 Cr..
- For Investments, as of Sep 2024, the value is ₹4,945.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,462.00 Cr. (Mar 2024) to ₹4,945.00 Cr., marking an increase of 483.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹5,129.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,123.00 Cr. (Mar 2024) to ₹5,129.00 Cr., marking an increase of 6.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹29,038.00 Cr.. The value appears strong and on an upward trend. It has increased from 27,712.00 Cr. (Mar 2024) to ₹29,038.00 Cr., marking an increase of 1,326.00 Cr..
Notably, the Reserves (17,480.00 Cr.) exceed the Borrowings (4,931.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -7.00 | -5.00 | -4.00 | -4.00 | -1.00 | -1.00 | -1.00 | -2.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 26 | 24 | 21 | 25 | 18 | 22 | 19 | 21 |
| Inventory Days | 189 | 186 | 211 | 204 | 180 | 234 | 242 | 164 |
| Days Payable | 258 | 223 | 179 | 173 | 213 | 211 | 209 | 178 |
| Cash Conversion Cycle | -43 | -13 | 53 | 55 | -14 | 45 | 52 | 8 |
| Working Capital Days | -29 | -26 | -25 | -37 | -24 | -21 | -18 | -21 |
| ROCE % | 6% | 4% | 4% | 10% | 7% | 8% | 7% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Growth Fund | 1,635,069 | 1.8 | 344.06 | 1,635,069 | 2025-04-22 17:25:37 | 0% |
| Sundaram Mid Cap Fund | 897,062 | 2.46 | 215.69 | 897,062 | 2025-04-22 17:25:37 | 0% |
| Sundaram Mid Cap Fund - Institutional Plan | 897,062 | 2.46 | 215.69 | 897,062 | 2025-04-22 17:25:37 | 0% |
| ICICI Prudential MidCap Fund | 507,962 | 2.78 | 122.13 | 507,962 | 2025-04-22 17:25:37 | 0% |
| HSBC Midcap Fund | 426,432 | 1.12 | 89.73 | 426,432 | 2025-04-22 17:25:37 | 0% |
| Sundaram Large and Mid Cap Fund | 250,000 | 1.09 | 60.11 | 250,000 | 2025-04-22 17:25:37 | 0% |
| UTI Nifty200 Momentum 30 Index Fund | 212,606 | 1.93 | 51.12 | 212,606 | 2025-04-22 17:25:37 | 0% |
| UTI Large & Mid Cap Fund | 206,177 | 2.48 | 49.57 | 206,177 | 2025-04-22 17:25:37 | 0% |
| Invesco India Arbitrage Fund | 219,500 | 0.53 | 46.19 | 219,500 | 2025-04-22 17:25:37 | 0% |
| ICICI Prudential Commodities Fund | 182,381 | 3.31 | 43.85 | 182,381 | 2025-04-22 17:25:37 | 0% |
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 44.05 | 55.22 | 61.84 | 65.65 | 11.61 |
| Diluted EPS (Rs.) | 44.03 | 55.19 | 61.84 | 65.55 | 11.58 |
| Cash EPS (Rs.) | 123.74 | 98.92 | 129.95 | 135.41 | 90.56 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 868.79 | 851.03 | 851.84 | 684.49 | 542.87 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 868.79 | 851.03 | 851.84 | 684.49 | 542.87 |
| Revenue From Operations / Share (Rs.) | 773.21 | 731.89 | 610.05 | 568.76 | 496.10 |
| PBDIT / Share (Rs.) | 155.47 | 132.65 | 139.78 | 160.70 | 117.95 |
| PBIT / Share (Rs.) | 76.63 | 62.11 | 72.97 | 92.49 | 39.59 |
| PBT / Share (Rs.) | 56.32 | 41.68 | 61.95 | 76.11 | 18.31 |
| Net Profit / Share (Rs.) | 44.89 | 28.38 | 63.13 | 67.19 | 12.21 |
| NP After MI And SOA / Share (Rs.) | 43.47 | 55.95 | 61.84 | 66.54 | 11.49 |
| PBDIT Margin (%) | 20.10 | 18.12 | 22.91 | 28.25 | 23.77 |
| PBIT Margin (%) | 9.91 | 8.48 | 11.96 | 16.26 | 7.98 |
| PBT Margin (%) | 7.28 | 5.69 | 10.15 | 13.38 | 3.69 |
| Net Profit Margin (%) | 5.80 | 3.87 | 10.34 | 11.81 | 2.46 |
| NP After MI And SOA Margin (%) | 5.62 | 7.64 | 10.13 | 11.69 | 2.31 |
| Return on Networth / Equity (%) | 5.03 | 6.62 | 7.29 | 9.74 | 2.12 |
| Return on Capital Employeed (%) | 6.25 | 5.44 | 6.71 | 10.15 | 4.88 |
| Return On Assets (%) | 2.97 | 4.05 | 4.59 | 5.64 | 1.08 |
| Long Term Debt / Equity (X) | 0.27 | 0.20 | 0.12 | 0.16 | 0.33 |
| Total Debt / Equity (X) | 0.28 | 0.23 | 0.19 | 0.23 | 0.44 |
| Asset Turnover Ratio (%) | 0.55 | 0.53 | 0.01 | 0.01 | 0.01 |
| Current Ratio (X) | 1.76 | 1.65 | 1.57 | 1.31 | 1.18 |
| Quick Ratio (X) | 1.48 | 1.35 | 1.38 | 1.12 | 0.97 |
| Inventory Turnover Ratio (X) | 4.13 | 4.94 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 20.46 | 16.32 | 0.00 | 0.00 | 34.37 |
| Dividend Payout Ratio (CP) (%) | 7.27 | 7.22 | 0.00 | 0.00 | 4.39 |
| Earning Retention Ratio (%) | 79.54 | 83.68 | 0.00 | 0.00 | 65.63 |
| Cash Earning Retention Ratio (%) | 92.73 | 92.78 | 0.00 | 0.00 | 95.61 |
| Interest Coverage Ratio (X) | 7.65 | 10.49 | 12.80 | 9.81 | 5.54 |
| Interest Coverage Ratio (Post Tax) (X) | 3.21 | 3.88 | 6.75 | 5.10 | 1.57 |
| Enterprise Value (Cr.) | 41059.80 | 39904.23 | 30682.95 | 32013.43 | 13908.50 |
| EV / Net Operating Revenue (X) | 2.79 | 2.95 | 2.72 | 3.04 | 1.44 |
| EV / EBITDA (X) | 13.90 | 16.26 | 11.87 | 10.77 | 6.05 |
| MarketCap / Net Operating Revenue (X) | 2.51 | 2.68 | 2.45 | 2.79 | 0.98 |
| Retention Ratios (%) | 79.53 | 83.67 | 0.00 | 0.00 | 65.62 |
| Price / BV (X) | 2.25 | 2.32 | 1.76 | 2.33 | 0.90 |
| Price / Net Operating Revenue (X) | 2.51 | 2.68 | 2.45 | 2.79 | 0.98 |
| EarningsYield | 0.02 | 0.02 | 0.04 | 0.04 | 0.02 |
After reviewing the key financial ratios for Dalmia Bharat Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 44.05. This value is within the healthy range. It has decreased from 55.22 (Mar 23) to 44.05, marking a decrease of 11.17.
- For Diluted EPS (Rs.), as of Mar 24, the value is 44.03. This value is within the healthy range. It has decreased from 55.19 (Mar 23) to 44.03, marking a decrease of 11.16.
- For Cash EPS (Rs.), as of Mar 24, the value is 123.74. This value is within the healthy range. It has increased from 98.92 (Mar 23) to 123.74, marking an increase of 24.82.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 868.79. It has increased from 851.03 (Mar 23) to 868.79, marking an increase of 17.76.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 868.79. It has increased from 851.03 (Mar 23) to 868.79, marking an increase of 17.76.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 773.21. It has increased from 731.89 (Mar 23) to 773.21, marking an increase of 41.32.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 155.47. This value is within the healthy range. It has increased from 132.65 (Mar 23) to 155.47, marking an increase of 22.82.
- For PBIT / Share (Rs.), as of Mar 24, the value is 76.63. This value is within the healthy range. It has increased from 62.11 (Mar 23) to 76.63, marking an increase of 14.52.
- For PBT / Share (Rs.), as of Mar 24, the value is 56.32. This value is within the healthy range. It has increased from 41.68 (Mar 23) to 56.32, marking an increase of 14.64.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 44.89. This value is within the healthy range. It has increased from 28.38 (Mar 23) to 44.89, marking an increase of 16.51.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 43.47. This value is within the healthy range. It has decreased from 55.95 (Mar 23) to 43.47, marking a decrease of 12.48.
- For PBDIT Margin (%), as of Mar 24, the value is 20.10. This value is within the healthy range. It has increased from 18.12 (Mar 23) to 20.10, marking an increase of 1.98.
- For PBIT Margin (%), as of Mar 24, the value is 9.91. This value is below the healthy minimum of 10. It has increased from 8.48 (Mar 23) to 9.91, marking an increase of 1.43.
- For PBT Margin (%), as of Mar 24, the value is 7.28. This value is below the healthy minimum of 10. It has increased from 5.69 (Mar 23) to 7.28, marking an increase of 1.59.
- For Net Profit Margin (%), as of Mar 24, the value is 5.80. This value is within the healthy range. It has increased from 3.87 (Mar 23) to 5.80, marking an increase of 1.93.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 5.62. This value is below the healthy minimum of 8. It has decreased from 7.64 (Mar 23) to 5.62, marking a decrease of 2.02.
- For Return on Networth / Equity (%), as of Mar 24, the value is 5.03. This value is below the healthy minimum of 15. It has decreased from 6.62 (Mar 23) to 5.03, marking a decrease of 1.59.
- For Return on Capital Employeed (%), as of Mar 24, the value is 6.25. This value is below the healthy minimum of 10. It has increased from 5.44 (Mar 23) to 6.25, marking an increase of 0.81.
- For Return On Assets (%), as of Mar 24, the value is 2.97. This value is below the healthy minimum of 5. It has decreased from 4.05 (Mar 23) to 2.97, marking a decrease of 1.08.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.27. This value is within the healthy range. It has increased from 0.20 (Mar 23) to 0.27, marking an increase of 0.07.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.28. This value is within the healthy range. It has increased from 0.23 (Mar 23) to 0.28, marking an increase of 0.05.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.55. It has increased from 0.53 (Mar 23) to 0.55, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 24, the value is 1.76. This value is within the healthy range. It has increased from 1.65 (Mar 23) to 1.76, marking an increase of 0.11.
- For Quick Ratio (X), as of Mar 24, the value is 1.48. This value is within the healthy range. It has increased from 1.35 (Mar 23) to 1.48, marking an increase of 0.13.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.13. This value is within the healthy range. It has decreased from 4.94 (Mar 23) to 4.13, marking a decrease of 0.81.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 20.46. This value is within the healthy range. It has increased from 16.32 (Mar 23) to 20.46, marking an increase of 4.14.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 7.27. This value is below the healthy minimum of 20. It has increased from 7.22 (Mar 23) to 7.27, marking an increase of 0.05.
- For Earning Retention Ratio (%), as of Mar 24, the value is 79.54. This value exceeds the healthy maximum of 70. It has decreased from 83.68 (Mar 23) to 79.54, marking a decrease of 4.14.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 92.73. This value exceeds the healthy maximum of 70. It has decreased from 92.78 (Mar 23) to 92.73, marking a decrease of 0.05.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 7.65. This value is within the healthy range. It has decreased from 10.49 (Mar 23) to 7.65, marking a decrease of 2.84.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 3.21. This value is within the healthy range. It has decreased from 3.88 (Mar 23) to 3.21, marking a decrease of 0.67.
- For Enterprise Value (Cr.), as of Mar 24, the value is 41,059.80. It has increased from 39,904.23 (Mar 23) to 41,059.80, marking an increase of 1,155.57.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.79. This value is within the healthy range. It has decreased from 2.95 (Mar 23) to 2.79, marking a decrease of 0.16.
- For EV / EBITDA (X), as of Mar 24, the value is 13.90. This value is within the healthy range. It has decreased from 16.26 (Mar 23) to 13.90, marking a decrease of 2.36.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.51. This value is within the healthy range. It has decreased from 2.68 (Mar 23) to 2.51, marking a decrease of 0.17.
- For Retention Ratios (%), as of Mar 24, the value is 79.53. This value exceeds the healthy maximum of 70. It has decreased from 83.67 (Mar 23) to 79.53, marking a decrease of 4.14.
- For Price / BV (X), as of Mar 24, the value is 2.25. This value is within the healthy range. It has decreased from 2.32 (Mar 23) to 2.25, marking a decrease of 0.07.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.51. This value is within the healthy range. It has decreased from 2.68 (Mar 23) to 2.51, marking a decrease of 0.17.
- For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Dalmia Bharat Ltd:
- Net Profit Margin: 5.8%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.25% (Industry Average ROCE: 10.92%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.03% (Industry Average ROE: 15.7%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.21
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.48
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 47.5 (Industry average Stock P/E: 49.89)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.28
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.8%
About the Company - Qualitative Analysis
Dalmia Bharat Ltd. is a Public Limited Listed company incorporated on 12/07/2013 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L14200TN2013PLC112346 and registration number is 112346. Currently Company is involved in the business activities of Manufacture of portland cement, aluminous cement, slag cement and similar hydraulic cement. Company's Total Operating Revenue is Rs. 202.00 Cr. and Equity Capital is Rs. 38.00 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | Dalmiapuram, Lalgudi, Tiruchirapalli Dist. Tamil Nadu 621651 | investorrelations@dalmiabharat.com https://www.dalmiabharat.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Yadu Hari Dalmia | Chairman & Non-Exe.Director |
| Mr. Gautam Dalmia | Managing Director |
| Mr. Puneet Yadu Dalmia | Managing Director & CEO |
| Dr. Niddodi Subrao Rajan | Non Executive Director |
| Mr. Paul Heinz Hugentobler | Ind. Non-Executive Director |
| Mr. Anuj Gulati | Ind. Non-Executive Director |
| Mrs. Anuradha Mookerjee | Ind. Non-Executive Director |
| Mr. Haigreve Khaitan | Independent Director |
FAQ
What is the intrinsic value of Dalmia Bharat Ltd?
Dalmia Bharat Ltd's intrinsic value (as of 25 April 2025) is ₹1626.09 — 17.62% lower the current market price of 1,974.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 36,947 Cr. market cap, FY2025-2026 high/low of ₹1,983/1,601, reserves of 17,480 Cr, and liabilities of 29,038 Cr.
What is the Market Cap of Dalmia Bharat Ltd?
The Market Cap of Dalmia Bharat Ltd is 36,947 Cr..
What is the current Stock Price of Dalmia Bharat Ltd as on 25 April 2025?
The current stock price of Dalmia Bharat Ltd as on 25 April 2025 is 1,974.
What is the High / Low of Dalmia Bharat Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Dalmia Bharat Ltd stocks is ₹1,983/1,601.
What is the Stock P/E of Dalmia Bharat Ltd?
The Stock P/E of Dalmia Bharat Ltd is 47.5.
What is the Book Value of Dalmia Bharat Ltd?
The Book Value of Dalmia Bharat Ltd is 926.
What is the Dividend Yield of Dalmia Bharat Ltd?
The Dividend Yield of Dalmia Bharat Ltd is 0.46 %.
What is the ROCE of Dalmia Bharat Ltd?
The ROCE of Dalmia Bharat Ltd is 5.97 %.
What is the ROE of Dalmia Bharat Ltd?
The ROE of Dalmia Bharat Ltd is 4.60 %.
What is the Face Value of Dalmia Bharat Ltd?
The Face Value of Dalmia Bharat Ltd is 2.00.